Showing items 1416-1465 of 2489 (50 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-02-02T02:21:34Z |
The benefit of mass eradication of helicobacter pylori infection: A community-based study of gastric cancer prevention
|
Lee Y.-C.; Chen T.H.-H.; Chiu H.-M.; Shun C.-T.; Chiang H.; Liu T.-Y.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:33Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lo J.-L.; Tseng P.-H.; Chiu H.-M.; Lee J.-M.; Ko J.-Y.; Lou P.-J.; MING-SHIANG WU; Lee Y.-C.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:33Z |
Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma
|
Hsu Y.-C.; Ho H.J.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:32Z |
Adjuvant treatments for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
|
Liao W.-C.; Chien K.-L.; Lin Y.-L.; MING-SHIANG WU; Lin J.-T.; Wang H.-P.; Tu Y.-K. |
| 臺大學術典藏 |
2021-02-02T02:21:32Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU; Kuo K.N.; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:31Z |
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
|
Lee Y.-C.; Chiu H.-M.; Chiang T.-H.; Yen A.M.-F.; Chiu S.Y.-H.; Chen S.L.-S.; Fann J.C.-Y.; Yeh Y.-P.; Liao C.-S.; Hu T.-H.; Tu C.-H.; Tseng P.-H.; Chen C.-C.; Chen M.-J.; Liou J.-M.; Liao W.-C.; Lai Y.-P.; Wang C.-P.; Ko J.-Y.; Wang H.-P.; Chiang H.; Lin J.-T.; Chen H.-H.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:30Z |
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma
|
Liao F.; Hsu Y.-C.; Kuo S.-H.; Yang Y.-C.; Chen J.-P.; Hsu P.-N.; Lin C.-W.; Chen L.-T.; Cheng A.-L.; Fann C.S.J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:29Z |
Normal values and symptom correlation of a simplified oatmeal-based gastric emptying study in the Chinese population
|
Tseng P.-H.; Wu Y.-W.; Lee Y.-C.; Cheng M.-F.; Tzen K.-Y.; Wang H.-P.; Lin J.-T.; Hsieh S.-T.; Yang W.-S.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:29Z |
Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance
|
Sheu B.-S.; Wu C.-Y.; MING-SHIANG WU; Chiu C.-T.; Lin C.-C.; Hsu P.-I.; Cheng H.-C.; Lee T.-Y.; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:28Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Hsu Y.-C.; Lin J.-T.; Ho H.J.; Kao Y.-H.; Huang Y.-T.; Hsiao N.-W.; MING-SHIANG WU; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:27Z |
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
|
Chang L.-C.; Chiu H.-M.; Shun C.-T.; Liang J.-T.; Lin J.-T.; Chen C.-C.; Lee Y.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:27Z |
Formyl peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer
|
Cheng T.-Y.; MING-SHIANG WU; Lin J.-T.; Lin M.-T.; Shun C.-T.; Hua K.-T.; Kuo M.-L. |
| 臺大學術典藏 |
2021-02-02T02:21:26Z |
Smoking, drinking, and pancreatitis: A population-based cohort study in Taiwan
|
Lin H.-H.; Chang H.-Y.; Chiang Y.-T.; MING-SHIANG WU; Lin J.-T.; Liao W.-C. |
| 臺大學術典藏 |
2021-02-02T02:21:25Z |
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective
|
Wu Y.-W.; Tseng P.-H.; Lee Y.-C.; Wang S.-Y.; Chiu H.-M.; Tu C.-H.; Wang H.-P.; Lin J.-T.; MING-SHIANG WU; Yang W.-S. |
| 臺大學術典藏 |
2021-02-02T02:21:22Z |
Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Ho H.J.; Yang H.-R.; MING-SHIANG WU; Kuo K.N.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:21Z |
Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Ho H.J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:21Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Cheng A.; Sheng W.-H.; Liou J.-M.; Wang H.-P.; MING-SHIANG WU; Lin J.-T.; Chang S.-C. |
| 臺大學術典藏 |
2021-02-02T02:21:20Z |
Association between antiviral treatment and extrahepatic outcomes in patients with hepatitis C virus infection
|
Hsu Y.-C.; Ho H.J.; Huang Y.-T.; Wang H.-H.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:20Z |
Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis
|
Liao W.-C.; Tu Y.-K.; MING-SHIANG WU; Lin J.-T.; Wang H.-P.; Chien K.-L. |
| 臺大學術典藏 |
2021-02-02T02:21:19Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; MING-SHIANG WU; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:18Z |
Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
|
Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; Liou J.-M.; MING-SHIANG WU; Chang W.-L.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:17Z |
Associations of circulating gut hormone and adipocytokine levels with the spectrum of gastroesophageal reflux disease
|
Tseng P.-H.; Yang W.-S.; Liou J.-M.; Lee Y.-C.; Wang H.-P.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:17Z |
Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteria
|
Fang Y.-J.; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:15Z |
Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:14Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:14Z |
Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trial
|
Liou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:11Z |
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Zeng Y.-S.; Chen Y.-J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:10Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative Patients
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; Fang Y.-J.; Hung H.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:10Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:08Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Liou J.-M.; Fang Y.-J.; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:07Z |
Treatment of Helicobacter pylori infection: Where are we now?
|
Liou J.-M.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:06Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:05Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2021-02-02T02:21:03Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Sheu B.-S.; MING-SHIANG WU; Chiu C.-T.; Lo J.-C.; Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:02Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Hsu Y.-C.; Mo L.-R.; Chang C.-Y.; MING-SHIANG WU; Yang T.-H.; Kao J.-H.; Chen C.-C.; Tseng C.-H.; Tai C.-M.; Lin C.-W.; Wu C.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:21:01Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:21:01Z |
The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease
|
Lee T.-Y.; Wu J.-C.; Yu S.-H.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:01Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Kuo Y.-T.; Liou J.-M.; El-Omar E.M.; Wu J.-Y.; Leow A.H.R.; Goh K.L.; Das R.; Lu H.; Lin J.-T.; Tu Y.-K.; Yamaoka Y.; MING-SHIANG WU; for the, Asian Pacific Alliance on Helicobacter; Microbiota |
| 臺大學術典藏 |
2021-02-02T02:21:00Z |
Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy
|
Chien N.-H.; Huang Y.-T.; Wu C.-Y.; Chang C.-Y.; MING-SHIANG WU; Kao J.-H.; Mo L.-R.; Tai C.-M.; Lin C.-W.; Yang T.-H.; Lin J.-T.; Hsu Y.-C. |
| 臺大學術典藏 |
2021-02-02T02:20:59Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Yeo Y.H.; Shiu S.-I.; Ho H.J.; Zou B.; Lin J.-T.; MING-SHIANG WU; Liou J.-M.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:59Z |
Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study
|
Leung W.K.; Ho H.J.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:57Z |
Survey of the adherence to the consensus of gastroesophageal reflux disease before and after the implementation course
|
Liou J.-M.; Sheu B.-S.; Lee Y.-C.; Cheng H.-C.; Chang W.-L.; Wu D.-C.; Hsu P.-I.; Wu C.-Y.; MING-SHIANG WU; Chiu C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2021-02-02T02:20:56Z |
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
|
Hsu Y.-C.; Ho H.-J.; Lee T.-Y.; Huang Y.-T.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y.; El-Serag H.B. |
| 臺大學術典藏 |
2021-02-02T02:20:55Z |
Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
|
Lee T.-Y.; Hsu Y.-C.; Yu S.-H.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:54Z |
Nutrition therapy in esophageal cancer—Consensus statement of the Gastroenterological Society of Taiwan
|
Chen M.-J.; Wu I.-C.; Chen Y.-J.; Wang T.-E.; Chang Y.-F.; Yang C.-L.; Huang W.-C.; Chang W.-K.; Sheu B.-S.; MING-SHIANG WU; Lin J.-T.; Chu C.-H. |
| 臺大學術典藏 |
2021-02-02T02:20:54Z |
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
|
Hsu Y.-C.; Yip T.C.-F.; Ho H.J.; Wong V.W.-S.; Huang Y.-T.; El-Serag H.B.; Lee T.-Y.; MING-SHIANG WU; Lin J.-T.; Wong G.L.-H.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
The implementation of the consensus on the management of Helicobacter pylori and barriers to consensus
|
Cheng H.-C.; Liou J.-M.; Luo J.-C.; Chiu C.-T.; MING-SHIANG WU; Lee Y.-C.; Wu C.-Y.; Wu D.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Sheu B.-S. |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2021-02-02T02:20:53Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium |
Showing items 1416-1465 of 2489 (50 Page(s) Totally)
<< < 24 25 26 27 28 29 30 31 32 33 > >>
View [10|25|50] records per page
